1.1 Articolo su Rivista/Article

1.1 Articolo su Rivista/Article: [13853] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 4.401 a 4.420 di 13.853

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis

2021-01-01 Aimo, A.; Rapezzi, C.; Perfetto, F.; Cappelli, F.; Palladini, G.; Obici, L.; Merlini, G.; Di Bella, G.; Serenelli, M.; Zampieri, M.; Milani, P.; Licordari, R.; Teresi, L.; Ribarich, N.; Castiglione, V.; Quattrone, F.; De Rosis, S.; Vergaro, G.; Panichella, G.; Emdin, M.; Passino, C.

The central role of invasive functional coronary assessment for patients with ischemic heart disease

2021-01-01 Niccoli, G.; Morrone, D.; De Rosa, S.; Montone, R. A.; Polimeni, A.; Aimo, A.; Mancone, M.; Muscoli, S.; Pedrinelli, R.; Indolfi, C.

The Left Ventricular Mass-to-Strain Ratio: Enough to Differentiate ATTR From AL Cardiac Amyloidosis?

2021-01-01 Aimo, A.; Castiglione, V.; Barison, A.; Chubuchnyi, V.; Emdin, M.

Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure

2021-01-01 Vergaro, G.; Aimo, A.; Taurino, E.; Del Franco, A.; Fabiani, I.; Prontera, C.; Masotti, S.; Musetti, V.; Emdin, M.; Passino, C.

Oral anticoagulation in patients with atrial fibrillation and stage 4 or 5 chronic kidney disease

2020-01-01 Petricciuolo, S.; Aimo, A.; De Caterina, R.

Cardiac biomarkers for outcome prediction in infant bronchiolitis: Too soon to discard troponin?

2021-01-01 Clerico, A.; Aimo, A.; Cantinotti, M.

Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis

2021-01-01 Radico, F.; Di Castelnuovo, A.; Aimo, A.; Zimarino, M.; Knuuti, J.; Rossi, S.; Pastormerlo, L. E.; Zyw, L.; Orsini, E.; Iacoviello, L.; Neglia, D.; Emdin, M.; de Gaetano, G.; De Caterina, R.

Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure

2021-01-01 Aimo, A.; Vergaro, G.; Passino, C.; Clerico, A.

Cardiac magnetic resonance in patients with ARVC and family members: the potential role of native T1 mapping

2021-01-01 Georgiopoulos, G.; Zampieri, M.; Molaro, S.; Chaloupka, A.; Aimo, A.; Barra, B.; Roberts, L.; Monje-Garcia, L.; Evans, C.; Sheikh, N.; Bastiaenen, R.; Cooklin, M.; Masci, P. -G.; Carr-White, G.; Finocchiaro, G.; Chiribiri, A.

Longitudinal changes in cardiac biomarkers and outcome in heart failure: Sex-related differences

2021-01-01 Aimo, A.

Myocardial perfusion years after radiation therapy for left-sided breast cancer: Normal or abnormal? This is the question

2019-01-01 Aimo, A.; Gimelli, A.

Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis

2021-01-01 Pucci, A.; Aimo, A.; Musetti, V.; Barison, A.; Vergaro, G.; Genovesi, D.; Giorgetti, A.; Masotti, S.; Arzilli, C.; Prontera, C.; Pastormerlo, L. E.; Coceani, M. A.; Ciardetti, M.; Martini, N.; Palmieri, C.; Passino, C.; Rapezzi, C.; Emdin, M.

Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Letter regarding the article ‘Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial’

2020-01-01 Aimo, A.; Castiglione, V.; Lombardi, C. M.

Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets

2021-01-01 Fabiani, I.; Aimo, A.; Grigoratos, C.; Castiglione, V.; Gentile, F.; Saccaro, L. F.; Arzilli, C.; Cardinale, D.; Passino, C.; Emdin, M.

Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient

2021-01-01 Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M.

Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure

2021-01-01 Vergaro, G.; Aimo, A.; Campora, A.; Castiglione, V.; Prontera, C.; Masotti, S.; Musetti, V.; Chianca, M.; Valleggi, A.; Spini, V.; Emdin, M.; Passino, C.

Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides

2021-01-01 Castiglione, V.; Vergaro, G.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Battaglia, D.; Di Cecco, P.; Emdin, M.; Passino, C.

Digoxin use in patients with cardiovascular diseases: An old remedy for future medicine?

2021-01-01 Barison, A.; Aimo, A.

Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification

2020-01-01 Aimo, A.; de Caterina, R.

Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction

2021-01-01 Gimelli, A.; Aimo, A.; Pasanisi, E. M.; Coceani, M. A.; Clemente, A.; Emdin, M.; Shaw, L. J.

Titolo	Data di pubblicazione	Autore(i)
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis	1-gen-2021	Aimo, A.; Rapezzi, C.; Perfetto, F.; Cappelli, F.; Palladini, G.; Obici, L.; Merlini, G.; Di Bella, G.; Serenelli, M.; Zampieri, M.; Milani, P.; Licordari, R.; Teresi, L.; Ribarich, N.; Castiglione, V.; Quattrone, F.; De Rosis, S.; Vergaro, G.; Panichella, G.; Emdin, M.; Passino, C.
The central role of invasive functional coronary assessment for patients with ischemic heart disease	1-gen-2021	Niccoli, G.; Morrone, D.; De Rosa, S.; Montone, R. A.; Polimeni, A.; Aimo, A.; Mancone, M.; Muscoli, S.; Pedrinelli, R.; Indolfi, C.
The Left Ventricular Mass-to-Strain Ratio: Enough to Differentiate ATTR From AL Cardiac Amyloidosis?	1-gen-2021	Aimo, A.; Castiglione, V.; Barison, A.; Chubuchnyi, V.; Emdin, M.
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure	1-gen-2021	Vergaro, G.; Aimo, A.; Taurino, E.; Del Franco, A.; Fabiani, I.; Prontera, C.; Masotti, S.; Musetti, V.; Emdin, M.; Passino, C.
Oral anticoagulation in patients with atrial fibrillation and stage 4 or 5 chronic kidney disease	1-gen-2020	Petricciuolo, S.; Aimo, A.; De Caterina, R.
Cardiac biomarkers for outcome prediction in infant bronchiolitis: Too soon to discard troponin?	1-gen-2021	Clerico, A.; Aimo, A.; Cantinotti, M.
Factors for heterogeneous outcomes of angina and myocardial ischemia without obstructive coronary atherosclerosis	1-gen-2021	Radico, F.; Di Castelnuovo, A.; Aimo, A.; Zimarino, M.; Knuuti, J.; Rossi, S.; Pastormerlo, L. E.; Zyw, L.; Orsini, E.; Iacoviello, L.; Neglia, D.; Emdin, M.; de Gaetano, G.; De Caterina, R.
Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure	1-gen-2021	Aimo, A.; Vergaro, G.; Passino, C.; Clerico, A.
Cardiac magnetic resonance in patients with ARVC and family members: the potential role of native T1 mapping	1-gen-2021	Georgiopoulos, G.; Zampieri, M.; Molaro, S.; Chaloupka, A.; Aimo, A.; Barra, B.; Roberts, L.; Monje-Garcia, L.; Evans, C.; Sheikh, N.; Bastiaenen, R.; Cooklin, M.; Masci, P. -G.; Carr-White, G.; Finocchiaro, G.; Chiribiri, A.
Longitudinal changes in cardiac biomarkers and outcome in heart failure: Sex-related differences	1-gen-2021	Aimo, A.
Myocardial perfusion years after radiation therapy for left-sided breast cancer: Normal or abnormal? This is the question	1-gen-2019	Aimo, A.; Gimelli, A.
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis	1-gen-2021	Pucci, A.; Aimo, A.; Musetti, V.; Barison, A.; Vergaro, G.; Genovesi, D.; Giorgetti, A.; Masotti, S.; Arzilli, C.; Prontera, C.; Pastormerlo, L. E.; Coceani, M. A.; Ciardetti, M.; Martini, N.; Palmieri, C.; Passino, C.; Rapezzi, C.; Emdin, M.
Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Letter regarding the article ‘Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial’	1-gen-2020	Aimo, A.; Castiglione, V.; Lombardi, C. M.
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets	1-gen-2021	Fabiani, I.; Aimo, A.; Grigoratos, C.; Castiglione, V.; Gentile, F.; Saccaro, L. F.; Arzilli, C.; Cardinale, D.; Passino, C.; Emdin, M.
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient	1-gen-2021	Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M.
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure	1-gen-2021	Vergaro, G.; Aimo, A.; Campora, A.; Castiglione, V.; Prontera, C.; Masotti, S.; Musetti, V.; Chianca, M.; Valleggi, A.; Spini, V.; Emdin, M.; Passino, C.
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides	1-gen-2021	Castiglione, V.; Vergaro, G.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Battaglia, D.; Di Cecco, P.; Emdin, M.; Passino, C.
Digoxin use in patients with cardiovascular diseases: An old remedy for future medicine?	1-gen-2021	Barison, A.; Aimo, A.
Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification	1-gen-2020	Aimo, A.; de Caterina, R.
Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction	1-gen-2021	Gimelli, A.; Aimo, A.; Pasanisi, E. M.; Coceani, M. A.; Clemente, A.; Emdin, M.; Shaw, L. J.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 4.401 a 4.420 di 13.853

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext7140
open4010
reserved1579
restricted1073
embargoed39
partially open12